Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

1.92USD
13 Nov 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$1.92
Open
$2.01
Day's High
$2.08
Day's Low
$1.91
Volume
100,550
Avg. Vol
112,868
52-wk High
$10.40
52-wk Low
$1.86

Chart for

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $387.58
Shares Outstanding(Mil.): 36.22
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -2.29 -- --
ROI: -50.00 -0.29 14.22
ROE: -52.94 0.40 15.99

Earnings vs. Estimates